Petra Minder

681 total citations
10 papers, 510 citations indexed

About

Petra Minder is a scholar working on Molecular Biology, Immunology and Allergy and Cancer Research. According to data from OpenAlex, Petra Minder has authored 10 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and Allergy and 4 papers in Cancer Research. Recurrent topics in Petra Minder's work include Cell Adhesion Molecules Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and CRISPR and Genetic Engineering (2 papers). Petra Minder is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and CRISPR and Genetic Engineering (2 papers). Petra Minder collaborates with scholars based in United States, Switzerland and Germany. Petra Minder's co-authors include James P. Quigley, Ewa Zając, Elena I. Deryugina, Anna Juncker‐Jensen, Tatyana A. Kupriyanova, Bernhard Schweighofer, Bruce E. Torbett, Mi Ae Park, Igor I. Slukvin and HyunJun Kang and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS Pathogens.

In The Last Decade

Petra Minder

10 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Minder United States 8 271 157 90 86 54 10 510
Viveka Nand Yadav United States 13 187 0.7× 216 1.4× 127 1.4× 107 1.2× 20 0.4× 27 538
Fan Zou China 13 248 0.9× 257 1.6× 314 3.5× 62 0.7× 68 1.3× 33 653
Anna Shmakova Russia 11 185 0.7× 57 0.4× 117 1.3× 83 1.0× 47 0.9× 45 418
Caryll Waugh Australia 11 299 1.1× 274 1.7× 171 1.9× 46 0.5× 25 0.5× 12 628
Mario Pujato United States 11 250 0.9× 157 1.0× 111 1.2× 55 0.6× 86 1.6× 20 594
Yaohong Tan United States 11 205 0.8× 131 0.8× 83 0.9× 48 0.6× 65 1.2× 15 576
Felipe Vences‐Catalán United States 12 228 0.8× 235 1.5× 110 1.2× 55 0.6× 24 0.4× 17 505
Anna Coenen-Stass United Kingdom 17 741 2.7× 238 1.5× 136 1.5× 272 3.2× 67 1.2× 28 1.1k
Gaëlle Picarda France 15 268 1.0× 195 1.2× 186 2.1× 68 0.8× 43 0.8× 26 620
Fulvia Troise Italy 12 251 0.9× 138 0.9× 147 1.6× 27 0.3× 43 0.8× 25 491

Countries citing papers authored by Petra Minder

Since Specialization
Citations

This map shows the geographic impact of Petra Minder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Minder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Minder more than expected).

Fields of papers citing papers by Petra Minder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Minder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Minder. The network helps show where Petra Minder may publish in the future.

Co-authorship network of co-authors of Petra Minder

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Minder. A scholar is included among the top collaborators of Petra Minder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Minder. Petra Minder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Humbert, Magali, Petra Minder, Anna M. Schläfli, et al.. (2022). Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions. Cell Death and Disease. 13(5). 448–448. 34 indexed citations
3.
Simpson, Elizabeth M., et al.. (2018). CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells. Molecular Therapy — Methods & Clinical Development. 13. 27–39. 11 indexed citations
4.
Minder, Petra, et al.. (2018). Hexokinase Proteins Impart Distinct Functions in Myeloid Development and Cell Death. Blood. 132(Supplement 1). 5088–5088. 2 indexed citations
5.
Müller, Miryam, Johannes Prox, Philipp Arnold, et al.. (2016). Tetraspanin 8 is an interactor of the metalloprotease meprin β within tetraspanin-enriched microdomains. Biological Chemistry. 0(0). 1 indexed citations
6.
Müller, Miryam, Johannes Prox, Philipp Arnold, et al.. (2016). Tetraspanin 8 is an interactor of the metalloprotease meprin β within tetraspanin-enriched microdomains. Biological Chemistry. 397(9). 857–869. 10 indexed citations
7.
Minder, Petra, Ewa Zając, James P. Quigley, & Elena I. Deryugina. (2015). EGFR Regulates the Development and Microarchitecture of Intratumoral Angiogenic Vasculature Capable of Sustaining Cancer Cell Intravasation. Neoplasia. 17(8). 634–649. 62 indexed citations
8.
Kang, HyunJun, et al.. (2015). CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus. Molecular Therapy — Nucleic Acids. 4. e268–e268. 113 indexed citations
9.
Zając, Ewa, Bernhard Schweighofer, Tatyana A. Kupriyanova, et al.. (2013). Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood. 122(25). 4054–4067. 213 indexed citations
10.
Minder, Petra, et al.. (2012). Meprinα Transactivates the Epidermal Growth Factor Receptor (EGFR) via Ligand Shedding, thereby Enhancing Colorectal Cancer Cell Proliferation and Migration. Journal of Biological Chemistry. 287(42). 35201–35211. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026